The goal of this activity is to improve clinicians knowledge of the unmet treatment needs of patients with MDD and their awareness of how investigational agents with novel MOAs, especially those that target residual symptoms, such as anhedonia, may fit into the current treatment paradigm.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org
- Start Date: 2025-02-18 06:00:00
- End Date: 2025-02-18 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Janssen (Any division) - Amount: 184793.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest